Sofolanork

Sofolanork
Sofolanork (Sofosbuvir 400 mg) offers a cure for a wide variety of patients with chronic Hepatitis C.

Healthcare providers should decide what treatment is right for patients with chronic Hepatitis C, often based on:

  • Hepatitis C genotype
  • Prior treatment
  • The health of the liver
  • Other conditions

Sofolanork is taken as a single pill once daily with food. Sofolanork unique Alu-Alu strip package guards Hepatitis C patients against Microbiological contamination, humidity, temperature, light, counterfeiting and patient compliance. Moreover, it restores the quality of life for Hepatitis C patients because of its high efficacy and tolerability.

Based on the health of the liver, treatment may cure chronic Hepatitis C genotype 1 or 3, even if treating Hepatitis C was previously unsuccessful. A Cure means that No Hepatitis C virus was detected in the blood when tested 12 weeks after treatment ends. However, Sofolanork may not work as well in some patients with cirrhosis.  It is approved for people with HCV genotype 1, 2, 3, 4, 5 or 6.

Combined with Length of treatment
Genotype 1 Sofolanork & Daklanork 12 weeks (no cirrhosis)

24 weeks (with cirrhosis)

Genotype 2 Sofolanork & Daklanork No recommendation regarding which patients with
genotype 2 HCV are eligible for treatment with daclatasvir due to limited
evidence.
Genotype 3 Sofolanork & Daklanork & Ribavirin 24 weeks (with cirrhosis or treatment-experienced)
Genotype 4,5,6 Sofolanork & Daklanork

OR

Sofolanork & Pegylated Interferon &
Ribavirin

12 weeks (no cirrhosis)

24 weeks (with cirrhosis)

24 or 48 weeks

Sofolanork is generally well tolerated with no known specific side-effects of its own.The most common side-effects seen in people taking Daklanork with Sofolanork are fatigue, nausea and headache. However, taking Sofolanork with Interferon and Ribavirin can lead to additional side-effects including fever, muscle and joint aches, itching, depression, Anemia (low hemoglobin level) and Neutropenia (low white blood cell count).

Before taking Sofolanork, tell your healthcare provider about all your medical conditions, if you have liver problems other than hepatitis C infection; have had a liver transplant; have heart problems; or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Sofolanork will harm your unborn baby or pass into your breast milk.

IMPORTANT SAFETY INFORMATION
Do not start taking a new medicine without telling your healthcare provider. Sofolanork may affect the way other medicines work, and other medicines may affect how Sofolanork works.